MCC
TXMD icon

Money Concepts Capital’s TherapeuticsMD TXMD Stock Holding History

Money Concepts Capital’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7
Closed -$39 – 2711
2022
Q4 		$39 Buy
+7
New +$41 ﹤0.01% 3205
2022
Q2 		– Sell
-27
Closed -$1K – 2542
2022
Q1 		$1K Buy
+27
New +$425 ﹤0.01% 2613

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $711M AUM 9.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Money Concepts Capital's TXMD Position: Q1 2023 in Review

Money Concepts Capital sold out of TherapeuticsMD (TXMD) in Q1 2023, closing a stake of 7 shares — an estimated $39 sold.

Money Concepts Capital first reported a position in TXMD in Q1 2022 and held it in 2 quarters. The position peaked at $1K in Q1 2022. 41 funds tracked by Wall St. Rank hold TXMD as of Q1 2023.

  • Money Concepts Capital reported no remaining TherapeuticsMD position as of Q1 2023 after selling out during the quarter.
  • Money Concepts Capital sold 7 TherapeuticsMD shares in Q1 2023, an estimated $39.
  • Money Concepts Capital first reported a position in TherapeuticsMD in Q1 2022 and held it in 2 quarters.
  • Money Concepts Capital's TherapeuticsMD position peaked at $1K in Q1 2022.
  • 41 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2023.

Based on Money Concepts Capital's 13F filing for Q1 2023, filed 1 May 2023.